Insufficient scRNA-seq data for expression of SARS2 at single-cell level.
Insufficient scRNA-seq data for expression of SARS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 896.82 | 1445 / 1445 | 97% | 2.74 | 178 / 183 |
ovary | 100% | 993.80 | 180 / 180 | 96% | 4.03 | 414 / 430 |
intestine | 100% | 988.75 | 966 / 966 | 96% | 2.86 | 504 / 527 |
bladder | 100% | 1015.67 | 21 / 21 | 95% | 2.94 | 480 / 504 |
stomach | 100% | 971.08 | 359 / 359 | 94% | 2.76 | 270 / 286 |
prostate | 100% | 1407.15 | 245 / 245 | 92% | 2.05 | 460 / 502 |
thymus | 100% | 1627.82 | 653 / 653 | 91% | 1.98 | 549 / 605 |
skin | 100% | 1107.33 | 1809 / 1809 | 89% | 2.02 | 422 / 472 |
pancreas | 100% | 930.80 | 328 / 328 | 88% | 1.78 | 157 / 178 |
uterus | 100% | 963.26 | 170 / 170 | 88% | 2.35 | 402 / 459 |
lung | 98% | 753.40 | 569 / 578 | 88% | 2.32 | 1020 / 1155 |
adrenal gland | 100% | 1716.39 | 258 / 258 | 81% | 1.51 | 187 / 230 |
breast | 100% | 923.37 | 459 / 459 | 78% | 1.50 | 870 / 1118 |
brain | 99% | 845.36 | 2625 / 2642 | 77% | 1.59 | 545 / 705 |
kidney | 100% | 1392.91 | 89 / 89 | 76% | 1.39 | 683 / 901 |
liver | 100% | 1065.33 | 226 / 226 | 55% | 0.97 | 224 / 406 |
adipose | 100% | 733.03 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 4.58 | 80 / 80 |
spleen | 100% | 1284.10 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.12 | 1 / 1 |
muscle | 100% | 902.36 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 490.70 | 1319 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 755.16 | 845 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 650.90 | 817 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 1.96 | 39 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 2.01 | 25 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006434 | Biological process | seryl-tRNA aminoacylation |
GO_0070158 | Biological process | mitochondrial seryl-tRNA aminoacylation |
GO_0005739 | Cellular component | mitochondrion |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0004828 | Molecular function | serine-tRNA ligase activity |
GO_0000049 | Molecular function | tRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | SARS2 |
Protein name | Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) Seryl-tRNA synthetase 2, mitochondrial Seryl-tRNA synthetase 2, mitochondrial (cDNA FLJ58068, highly similar to Seryl-tRNA synthetase, mitochondrial) serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (Seryl-tRNA(Ser/Sec) synthetase) |
Synonyms | SARSM hCG_20526 |
Description | FUNCTION: Catalyzes the attachment of serine to tRNA(Ser). Is also probably able to aminoacylate tRNA(Sec) with serine, to form the misacylated tRNA L-seryl-tRNA(Sec), which will be further converted into selenocysteinyl-tRNA(Sec). . |
Accessions | ENST00000598831.5 M0R259 ENST00000455102.6 ENST00000594171.5 B4DJM9 M0QX29 ENST00000221431.11 [Q9NP81-1] Q9NP81 ENST00000634687.3 [Q9NP81-1] ENST00000635245.1 [Q9NP81-2] M0R1C0 ENST00000600042.5 [Q9NP81-2] ENST00000593754.1 M0R2H5 ENST00000598343.5 M0QWZ7 ENST00000430193.7 |